Proteomic Discovery of Potential Biomarkers in Zika Virus Infected Monkeys

Abstract

Zika virus (ZIKV) was first discovered in Macaca mulatta (rhesus monkeys) in 1947 and was found in humans in 1952. This virus can be transmitted via the bite of an infected mosquito, through sexual transmission, or from mother to child. Although most infected individuals are asymptomatic, some clinical symptoms of the virus include fever, joint pain, and rash, as well as microcephaly in infants of infected mothers. The World Health Organization (Geneva, Switzerland) announced a public health emergency in 2016 in response to outbreaks of ZIKV and its association with microcephaly; however, there has been limited progress in discerning how this virus impacts the host. Here, we report on the use of a proteomic pipeline to analyze plasma samples of ZIKV-infected macaques to identify biomarkers for the virus. The discovery of ZIKV biomarkers will assist in defining virus behavior during infection and will illustrate how the host is affected.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Feb 01, 2022
Accession Number
AD1159061

Entities

People

  • Bao Q. Tran
  • Daniel Carmany
  • Elizabeth S Dhummakupt
  • Gabrielle Rizzo
  • Phillip M Mach
  • Trevor Glaros

Organizations

  • United States Army Combat Capabilities Development Command

Tags

DTIC Thesaurus Topics

  • Animals
  • Blood
  • Cells
  • Cellular Structures
  • Chemistry
  • Diseases And Disorders
  • Infection
  • Infectious Diseases
  • Liquid Chromatography
  • Lymphocytes
  • Proteins
  • Public Health
  • Rna Viruses
  • Virus Diseases
  • Viruses
  • Zika Fever
  • Zika Virus

Fields of Study

  • Biology
  • Medicine

Readers

  • Oncology and Biomarker-Based Cancer Detection.
  • Virology (or Medical Virology).
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.

Technology Areas

  • Biotechnology